Colombel, J.
2595  Ergebnisse:
Personensuche X
?
2

A196 CSF2 AUTOANTIBODIES AS A SEROLOGICAL MARKER FOR CROHN'..:

Tai, S ; Del Valle, D ; Urango, R...
Journal of the Canadian Association of Gastroenterology.  7 (2024)  Supplement_1 - p. 154-155 , 2024
 
?
3

A167 CATEGORIZING ENDOSCOPIC SEVERITY OF CROHN'S DISEASE US..:

Pray, C ; Narula, N ; Wong, E C...
Journal of the Canadian Association of Gastroenterology.  5 (2022)  Supplement_1 - p. 45-47 , 2022
 
?
4

A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THER..:

Panaccione, R ; Ferrante, M ; Feagan, B G...
Journal of the Canadian Association of Gastroenterology.  5 (2022)  Supplement_1 - p. 43-45 , 2022
 
?
5

A5 GM-CSF AUTOANTIBODIES: PREDICTORS OF CROHN'S DISEASE DEV..:

Tai, S ; Remark, R ; Laface, I...
Journal of the Canadian Association of Gastroenterology.  4 (2021)  Supplement_1 - p. 5-6 , 2021
 
?
6

A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN'S DISEASE..:

Panaccione, R ; Colombel, J ; Bossuyt, P...
Journal of the Canadian Association of Gastroenterology.  2 (2019)  Supplement_2 - p. 136-137 , 2019
 
?
7

La Mannose-binding lectine et l'homéostasie intestinale:

Choteau, L. ; Vasseur, F. ; Lepretre, F....
Journal de Mycologie Médicale.  26 (2016)  2 - p. e3-e4 , 2016
 
?
13

Achievement of early deep remission is associated with lowe..:

Sandborn, W ; Colombel, J ; Lomax, K...
Inflammatory Bowel Diseases.  17 (2011)  suppl_1 - p. S61-S61 , 2011
 
?
14

A post-hoc analysis:

Sandborn, W ; Rutgeerts, P ; Reinisch, W...
Inflammatory Bowel Diseases.  17 (2011)  suppl_1 - p. S6-S6 , 2011
 
?
15

Adalimumab is effective for inducing clinical remission at ..:

Colombel, J ; Rutgeerts, P ; Reinisch, W...
Inflammatory Bowel Diseases.  17 (2011)  suppl_1 - p. S43-S44 , 2011
 
1-15
Mehr Literatur finden